Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide for Non-CF Bronchiectasis with Airway Limitation
NCT02782312Phase 4Completed
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salmeterol + fluticasone in bronchiectasis, sponsored by Shanghai Pulmonary Hospital. Primary endpoint: St George's Respiratory Questionnaire at 12 months. Started Jun 2011; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02782312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782312.